HSE to breach cost rules to buy new cancer drugs

The HSE is to spend €3.6m a year on new drugs to assist 230 patients with advanced forms of cancer.

HSE to breach cost rules to buy new cancer drugs

The decision is in breach of Department of Health cost guidelines but will save or at least prolong lives.

Irish patients will have access to four new cancer drugs this week, following approval by the National Cancer Control Programme (NCCP). The news was welcomed yesterday by the Irish Cancer Society.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

Lunchtime News

Newsletter

Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited